I now have all the material needed for a comprehensive Harrison's-based answer. Here is the complete write-up:
Lung Abscess - Harrison's Principles of Internal Medicine (22nd Ed.)
Definition
Lung abscess represents necrosis and cavitation of the lung following microbial infection. Abscesses can be single or multiple but are usually marked by a single dominant cavity >2 cm in diameter.
Classification
| Type | Description |
|---|
| Primary (~80%) | Arises from aspiration; caused chiefly by anaerobes; no underlying pulmonary/systemic condition |
| Secondary (~20%) | Arises in setting of bronchial obstruction (foreign body, tumor) or systemic immunocompromise |
| Acute | Duration <4-6 weeks |
| Chronic | ~40% of cases; duration >4-6 weeks |
Etiology / Microbiology (Harrison's Table 132-1)
| Clinical Condition | Pathogens |
|---|
| Primary lung abscess (aspiration risk) | Anaerobes: Peptostreptococcus spp., Prevotella spp., Bacteroides spp., milleri group streptococci; microaerophilic streptococci |
| Secondary lung abscess (immunocompromise) | S. aureus, gram-negative rods (P. aeruginosa, Enterobacteriaceae), Nocardia, Aspergillus, Mucorales, Cryptococcus, Legionella, Rhodococcus equi, Pneumocystis jirovecii |
| Embolic lesions | S. aureus (from endocarditis), Fusobacterium necrophorum (Lemierre's syndrome) |
| Endemic infections | M. tuberculosis, M. avium, M. kansasii, Coccidioides spp., Histoplasma capsulatum, Blastomyces spp., parasites (E. histolytica, Paragonimus westermani, Strongyloides) |
| Miscellaneous | S. aureus post-influenza/viral infection, Actinomyces spp. |
Epidemiology & Risk Factors
- More common in middle-aged men
- Major risk factor: aspiration (the common pathway)
- High-risk groups:
- Altered mental status, alcoholism, drug overdose, seizures
- Bulbar dysfunction, prior cerebrovascular events, neuromuscular disease
- Esophageal dysmotility, strictures, or tumors
- Gastroesophageal reflux; recumbent position
- Gingivitis/periodontal disease - gingival crevices colonized by anaerobes serve as the bacterial nidus; lung abscess is considered extremely rare in edentulous patients
Pathogenesis
Primary abscesses: Anaerobes + microaerophilic streptococci from gingival crevices are aspirated into lung parenchyma. Over 7-14 days, bacteria produce parenchymal necrosis and cavitation. Extent depends on host-pathogen interaction. Polymicrobial anaerobic infections produce more extensive tissue necrosis via synergistic virulence factors.
Secondary abscesses: Bronchial obstruction (by malignancy/foreign body) leads to distal atelectasis and superinfection. In immunocompromised patients, pathogens such as Aspergillus or Mucorales cause angioinvasion with subsequent necrosis.
Lemierre's syndrome: A specific form caused by Fusobacterium necrophorum - oropharyngeal/tonsillar infection leads to thrombophlebitis of the internal jugular vein with septic emboli to the lungs.
Clinical Features
Symptoms
- Subacute presentation typical - symptoms develop over days to weeks
- Cough - initially non-productive, later productive
- Foul-smelling / putrid sputum - hallmark feature indicating anaerobic infection
- Pleuritic chest pain
- Fever and chills
- Night sweats
- Hemoptysis - can occur, rarely massive
- Weight loss and fatigue (especially chronic cases)
- Dyspnea
Signs
- Fever (high-grade, often >39°C)
- Tachycardia, tachypnea
- Dullness to percussion over involved area
- Bronchial or amphoric breath sounds over the cavity
- Decreased breath sounds, crackles
- Clubbing may be present in chronic cases
- Signs of periodontal disease / poor dentition commonly present
- Altered mental status in high-risk (aspirating) patients
CT Scan Image (Harrison's Fig. 132-1)
Left panel: Early consolidation (black arrow). Right panel: Follow-up CT after treatment showing cavitation with air-fluid level (white arrow), classic for lung abscess.
Diagnosis
Laboratory
- CBC: Leukocytosis with left shift; leukopenia may suggest immunocompromise or overwhelming sepsis
- Elevated ESR, CRP
- Blood cultures (positive in ~15% of cases; more likely in secondary/embolic abscesses)
- HIV testing in appropriate patients
- Serum LDH may be elevated
Imaging
- CXR: Thick-walled cavity, often with air-fluid level; predilection for posterior segments of upper lobes and superior segments of lower lobes (gravity-dependent zones in recumbent patients)
- CT chest (preferred): Better defines cavity wall thickness, identifies satellite lesions, distinguishes abscess from empyema, detects endobronchial obstruction. Abscesses have thick irregular walls, surrounded by consolidation. CT is critical for ruling out underlying malignancy.
- Classic location: Right lower lobe > right upper lobe posterior segment > left lower lobe (gravity-dependent aspiration)
Microbiological Workup
- Sputum Gram stain and culture (including anaerobic cultures, AFB, fungal stains)
- Bronchoscopy with BAL - recommended, especially in: immunocompromised patients, failure to respond to empirical therapy, suspicion of endobronchial obstruction, or need to rule out malignancy
- BAL specimens should be sent for aerobic, anaerobic (if feasible), mycobacterial, fungal, Nocardia cultures
- CT-guided biopsy of cavity wall if malignancy suspected
- Blood cultures x2
- Thoracentesis if pleural effusion/empyema present
Management
Antibiotic Therapy
Empirical therapy for primary lung abscess (aspiration/anaerobes):
Harrison's recommends coverage directed against anaerobes and microaerophilic streptococci:
| Antibiotic | Notes |
|---|
| Amoxicillin-clavulanate (oral) | Good first choice; covers anaerobes + streptococci |
| Clindamycin | Historically the gold standard for anaerobes; IV then oral step-down |
| Beta-lactam/beta-lactamase inhibitor (IV: piperacillin-tazobactam, ampicillin-sulbactam) | For hospitalized patients |
| Metronidazole | NOT used alone - inadequate coverage for microaerophilic streptococci; use in combination |
| Carbapenems (imipenem, meropenem) | Reserve for severely ill or resistant cases |
For secondary abscesses, broaden coverage based on organism (e.g., anti-pseudomonal agents, anti-fungals for mold infections, anti-TB for mycobacteria).
Duration: Typically 3-6 weeks minimum; continue until cavity has resolved or shows marked improvement on imaging. Chronic abscesses may require even longer courses (up to several months).
Drainage
- Postural drainage / chest physiotherapy - important adjunct; position patient to drain dependent segments
- Bronchoscopic drainage - can be used to facilitate drainage and obtain cultures; generally not first-line but useful in non-resolving cases
- Percutaneous catheter drainage - indicated when:
- Abscess fails to respond to antibiotics after 4-6 weeks
- Large abscess (>6-8 cm)
- Communication with pleural space
- Immunocompromised host
- CT-guided; effective in selected patients
- Surgical resection (lobectomy) - reserved for:
- Failure of medical therapy and percutaneous drainage
- Massive hemoptysis
- Underlying malignancy
- Suspected drug-resistant organisms requiring tissue diagnosis
- Rare in the antibiotic era; carries significant morbidity
Supportive Care
- Adequate nutrition (often need supplemental nutrition in chronic cases)
- Bronchodilators if bronchospasm present
- Avoid bronchoscopy early if concern for cavity rupture
- Treat underlying conditions (periodontal disease, GER, etc.)
When to Reassess / Escalate
Harrison's emphasizes that ~85-90% of primary lung abscesses respond to antibiotics alone. Failure to improve after 4-6 weeks of appropriate therapy should prompt:
- Repeat imaging
- Bronchoscopy to rule out obstruction or malignancy
- Review of microbiology; culture-directed therapy
- Consideration of percutaneous or surgical drainage
Differential Diagnosis
Harrison's identifies the following conditions that must be excluded when a cavitary lung lesion is found:
| Category | Conditions |
|---|
| Infectious | Necrotizing pneumonia (Klebsiella, S. aureus, Streptococcus pyogenes), tuberculosis and non-tuberculous mycobacteria, endemic fungi (Coccidioides, Histoplasma, Blastomyces), invasive aspergillosis/mucormycosis, paragonimiasis, amoebic abscess (right lower lobe, may communicate with liver) |
| Malignancy | Primary lung carcinoma (squamous cell especially - cavitates with thick irregular walls), metastatic disease (cavitating mets), lymphoma |
| Inflammatory/Vasculitic | Granulomatosis with polyangiitis (GPA/Wegener's) - cavitating nodules; rheumatoid arthritis - necrobiotic nodules |
| Cystic/Structural | Infected pulmonary cyst or bulla, bronchogenic cyst, sequestration |
| Other | Cavitary infarct (pulmonary embolism), empyema with bronchopleural fistula (air-fluid level crossing pleural fissure - distinguished on CT), hydatid cyst (Echinococcus) |
Key distinguishing features:
- Thin-walled cavity - favors cyst, bulla, or resolved infarct
- Thick irregular wall - favors malignancy or active infection
- Air-fluid level - strongly supports abscess
- Location in dependent zones - strongly supports aspiration-related abscess
- Satellite lesions, lymphadenopathy - may suggest malignancy or TB
- Foul sputum + periodontal disease - virtually pathognomonic of anaerobic lung abscess
Complications
- Hemoptysis (can be massive/life-threatening)
- Bronchopleural fistula
- Empyema thoracis
- Mediastinitis (rare, very serious)
- Septicemia / metastatic infection
- Amyloidosis (rare, chronic cases)
Prognosis
- Primary lung abscess with anaerobes: excellent - ~85-90% cure with antibiotics alone
- Poor prognostic factors:
- Secondary abscess (underlying malignancy, immunocompromise)
- Cavity >6 cm
- Aerobic gram-negative or S. aureus causative organisms
- Age extremes
- Delayed diagnosis and treatment
- Obstruction from malignancy
Source: Harrison's Principles of Internal Medicine, 22nd Edition (2025), Chapter 132 - Lung Abscess (Baron RM, Baron BW, Barshak MB)